Koers Perspective Therapeutics, Inc.
Aandelen
CATX
US46489V1044
Medische apparatuur, benodigdheden & distributie
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
1,47 USD | +2,80% | +3,52% | +265,67% |
09/04 | PERSPECTIVE THERAPEUTICS, INC. : B. Riley ontvangt een koopadvies | ZM |
01/04 | PERSPECTIVE THERAPEUTICS, INC. : Oppenheimer handhaaft koopadvies | ZM |
Omzet 2024 * | - | Omzet 2025 * | - | Marktkapitalisatie | 863 mln. 810 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -48 mln. -45,06 mln. | Nettowinst (verlies) 2025 * | -56 mln. -52,57 mln. | EV/omzet 2024 * | - |
Nettoliquiditeiten 2024 * | - 0 | Nettoliquiditeiten 2025 * | - 0 | EV/omzet 2025 * | - |
K/w-verhouding 2024 * |
-16,3
x | K/w-verhouding 2025 * |
-12,8
x | Werknemers | 118 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 76,6% |
Recentste transcriptie over Perspective Therapeutics, Inc.
1 dag | +2,80% | ||
1 week | +3,52% | ||
Lopende maand | +23,53% | ||
1 maand | +52,33% | ||
3 maanden | +167,27% | ||
6 maanden | +390,65% | ||
Lopend jaar | +265,67% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Johan Spoor
CEO | Chief Executive Officer | 51 | 03-02-23 |
Mark Austin
DFI | Director of Finance/CFO | 37 | - |
Jonathan Hunt
DFI | Director of Finance/CFO | 57 | 03-02-23 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Heidi Henson
BRD | Director/Board Member | 58 | 01-06-23 |
Lori Woods
CHM | Chairman | 62 | 03-02-23 |
Director/Board Member | 58 | 03-02-23 |
Datum | Koers | Variatie | Volume |
---|---|---|---|
18-04-24 | 1,47 | +2,80% | 5 058 358 |
17-04-24 | 1,43 | -2,05% | 2 090 059 |
16-04-24 | 1,46 | -4,58% | 5 397 970 |
15-04-24 | 1,53 | +4,08% | 6 880 454 |
12-04-24 | 1,47 | +3,52% | 5 104 640 |
uitgestelde koers Nyse, 18 april 2024 om 22:00 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+265,67% | 863 mln. | |
-4,36% | 183 mld. | |
-3,87% | 105 mld. | |
-4,38% | 67,36 mld. | |
+8,23% | 51,77 mld. | |
+15,54% | 47,29 mld. | |
-1,73% | 40,2 mld. | |
+7,16% | 27,62 mld. | |
-16,74% | 21,75 mld. | |
-1,68% | 25,51 mld. |